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dialysis is increasingly popular, but
requires a live donor available at the right
time; currently, only 3% of patients under-
going transplantation have not been on
dialysis beforehand. Of those on dialysis,
only 23% overall and 39% of those aged
under 65 years are on the waiting list for a
deceased-donor transplant.2 Those not on
the list are either not interested in undergoing transplantation,
have medical barriers to safe transplantation, or are deemed
too frail to tolerate the procedure and subsequent immuno-
suppression.
Both patients and healthcare professionals believe that trans-
plantation, when feasible, is the preferred therapeutic option.
The scientific justification for this belief appears well founded.
In particular, there is strong evidence that patients who receive
transplants have a significant survival advantage. The annual
mortality rate of an age-matched population maintained by
transplantation is reduced about 80% beyond the first year
compared with those remaining on dialysis on the waiting list.3
The major difference is an up to 30-fold increase in relative risk
of cardiovascular events and death experienced by those on
long-term dialysis.4
In most Australian states, the average wait for a kidney from a
deceased donor is about 4 years, and some patients wait much
longer. The prospect of an extended wait on dialysis, as well as
the possibility that a suitable kidney may never become availa-
ble, drives some patients to consider more drastic options. One
pathway that is illegal in Australia, but open to those able to
afford it, is to travel overseas to purchase a kidney transplant. It
is not known how often Australians are choosing this option.
The report by Kennedy et al in this issue of the Journal
(page 224) describes the outcomes for 16 Sydney-based patients
who travelled overseas for kidney transplantation over the past
14 years. The risk of going down this path is evident, with an
increased risk of serious infection being a major hazard.
The annual rate of deceased-donor kidney transplants in
Australia for 2004 was a low 11 donors per million population.5
In 2003, the rate in Australia was 9.0 per million population,
compared with 33.8 in Spain, 23.9 in Austria, 24.8 in Belgium,
18.3 in France and 22.1 in the United States.6 Thus, the rate of
organ donation in this country is low compared with other
developed countries, and remains so despite the publicity
campaign promoting organ donation following the untimely
death following a brain injury of Australian cricket icon David
Hookes. One response to the shortage in deceased-donor organs
has been an increase in live kidney donation, and the proportion
of live donations in 2003 was 40% of total transplants. The
source of live kidney donors, previously restricted to close blood
relatives, has broadened in recent years to allow unrelated and
poorly matched emotionally connected donors. In the past 12
months, there have been several kidney transplants from altruis-
tic strangers donating to the pool of waiting
dialysis patients (so-called non-directed
donations). We can now add overseas com-
mercial sources as another contributor to
live kidney donation for Australian resi-
dents.
The real reasons for Australia’s poor per-
formance in deceased-donor organ pro-
curement have not been fully established. Clearly, there is no
lack of public support, which has exceeded 80% in repeated
surveys over many years.7 One outstanding observation that has
received little prominence and no systematic study is the high
and internationally competitive organ donor rate achieved in
South Australia. Over the last decade, South Australia has
consistently doubled the rate in all other Australian states.5 A
similar variation in performance is seen in the teaching hospitals
in capital cities, with some having double the rate of others. This
marked variation in the donation rates between states and
hospitals points to the probability that the barriers to increased
organ donation are within the hospital system.
The situation in Australia appears ripe for a collaborative
approach, such as one reported from the United States that
sought to “identify, learn, adapt, replicate and celebrate ‘break-
through’ practices associated with higher donation rates”.8 It is
remarkable that Australia has been so slow to fully examine and
take up systems that appear to work in some regions or
hospitals.
Positive moves are being made. A special working group of
the Australian Health Ministers’ Council has recently made 11
recommendations for change in the arrangements and process
for organ donation. The most fundamental recommendation is
for intensive care staff to routinely interrogate the Australian
Organ Donor Registry to ascertain the recorded intent of all
suitable patients with severe brain injury after the first set of
brain death tests. Relatives will then be informed of the intent
recorded on the Registry and be asked only if they are aware of
any change. Importantly, in this approach, the family will not
need to be asked for consent.
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performing hospitals and states, the embarrassing situation
driving dialysis patients to take the risks involved with travelling
overseas for kidney transplantation would not exist. Much
remains to be accomplished, but there are grounds for optimism
in believing Australia’s deceased-donor organ donation rate
could double if the barriers existing in the hospital system could
be removed.
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